Literature DB >> 16362402

Nicotine and nonnicotine factors in cigarette addiction.

Jed E Rose1.   

Abstract

RATIONALE: A great deal of research supports the role of nicotine in cigarette addiction. However, the effectiveness of nicotine replacement therapy (NRT) as a smoking cessation treatment has fallen short of initial hopes. A key reason may be that NRT does not address nonnicotine components of smoking reinforcement. These include constituents that provide reinforcing sensory stimulation, components that minimize excessive irritation from inhaled nicotine and other pharmacologically active compounds in cigarette smoke.
OBJECTIVE: Studies using various paradigms to dissociate nicotine from other components of smoking are summarized.
RESULTS: Nonnicotine components provide many rewarding effects, often surpassing the direct effects of nicotine. Substitutes for the sensory effects of smoking may be effective in relieving craving for cigarettes and in facilitating smoking cessation. Moreover, techniques for devaluing smoking-related cues may decrease craving and enhance subsequent abstinence. Promising approaches for devaluing smoke cues include extinction-based treatments employing denicotinized cigarettes and the use of nicotinic agonist and/or antagonist treatment during the weeks leading up to a quit attempt. Recent studies suggest that incorporating these approaches into a treatment program may significantly increase smoking abstinence rates. Preliminary findings also suggest that replacement of the effects of monoamine oxidase inhibitors contained in cigarette smoke may enhance quit rates.
CONCLUSIONS: While current NRT methods have been the mainstay of smoking cessation treatment and will likely continue to serve a useful role, the next stage of progress will likely entail the development of tools designed with recognition of the importance of nonnicotine components of cigarette smoking.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16362402     DOI: 10.1007/s00213-005-0250-x

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  96 in total

Review 1.  Incentive-sensitization and addiction.

Authors:  T E Robinson; K C Berridge
Journal:  Addiction       Date:  2001-01       Impact factor: 6.526

Review 2.  Concurrent agonist-antagonist administration for the analysis and treatment of drug dependence.

Authors:  J E Rose; E D Levin
Journal:  Pharmacol Biochem Behav       Date:  1992-01       Impact factor: 3.533

3.  Circulatory effects of nicotine aerosol inhalations and cigarette smoking in man.

Authors:  A Herxheimer
Journal:  Lancet       Date:  1967-10-07       Impact factor: 79.321

4.  Generation of a submicrometre nicotine aerosol for inhalation.

Authors:  J E Lux; R C Frecker
Journal:  Med Biol Eng Comput       Date:  1988-03       Impact factor: 2.602

5.  Sensory blockade of smoking satisfaction.

Authors:  J E Rose; D P Tashkin; A Ertle; M C Zinser; R Lafer
Journal:  Pharmacol Biochem Behav       Date:  1985-08       Impact factor: 3.533

6.  Evidence for nicotinic acetylcholine receptors on nasal trigeminal nerve endings of the rat.

Authors:  H Alimohammadi; W L Silver
Journal:  Chem Senses       Date:  2000-02       Impact factor: 3.160

7.  Blockade of smoking satisfaction using the peripheral nicotinic antagonist trimethaphan.

Authors:  J E Rose; E C Westman; F M Behm; M P Johnson; J S Goldberg
Journal:  Pharmacol Biochem Behav       Date:  1999-01       Impact factor: 3.533

8.  Refined cigarette smoke as a method for reducing nicotine intake.

Authors:  J E Rose; F Behm
Journal:  Pharmacol Biochem Behav       Date:  1987-10       Impact factor: 3.533

9.  Nicotine skin patch treatment increases abstinence, decreases withdrawal symptoms, and attenuates rewarding effects of smoking.

Authors:  E D Levin; E C Westman; R M Stein; E Carnahan; M Sanchez; S Herman; F M Behm; J E Rose
Journal:  J Clin Psychopharmacol       Date:  1994-02       Impact factor: 3.153

10.  A preliminary placebo-controlled trial of selegiline hydrochloride for smoking cessation.

Authors:  Tony P George; Jennifer C Vessicchio; Angelo Termine; Peter I Jatlow; Thomas R Kosten; Stephanie S O'Malley
Journal:  Biol Psychiatry       Date:  2003-01-15       Impact factor: 13.382

View more
  146 in total

1.  Attenuation of nicotine-taking and nicotine-seeking behavior by the mGlu2 receptor positive allosteric modulators AZD8418 and AZD8529 in rats.

Authors:  Xia Li; Manoranjan S D'Souza; Ana M Niño; James Doherty; Alan Cross; Athina Markou
Journal:  Psychopharmacology (Berl)       Date:  2016-02-13       Impact factor: 4.530

Review 2.  Nicotinic acetylcholine receptors: upregulation, age-related effects and associations with drug use.

Authors:  W E Melroy-Greif; J A Stitzel; M A Ehringer
Journal:  Genes Brain Behav       Date:  2015-12-23       Impact factor: 3.449

3.  The early time course of smoking withdrawal effects.

Authors:  Peter S Hendricks; Joseph W Ditre; David J Drobes; Thomas H Brandon
Journal:  Psychopharmacology (Berl)       Date:  2006-06-03       Impact factor: 4.530

4.  Conditioned reinforcement in rats established with self-administered nicotine and enhanced by noncontingent nicotine.

Authors:  Matthew I Palmatier; Xiu Liu; Gina L Matteson; Eric C Donny; Anthony R Caggiula; Alan F Sved
Journal:  Psychopharmacology (Berl)       Date:  2007-08-05       Impact factor: 4.530

5.  The reinforcement enhancing effects of nicotine depend on the incentive value of non-drug reinforcers and increase with repeated drug injections.

Authors:  Matthew I Palmatier; Gina L Matteson; Jessica J Black; Xiu Liu; Anthony R Caggiula; Laure Craven; Eric C Donny; Alan F Sved
Journal:  Drug Alcohol Depend       Date:  2007-01-19       Impact factor: 4.492

6.  The role of nicotinic acetylcholine receptors in the primary reinforcing and reinforcement-enhancing effects of nicotine.

Authors:  Matthew I Palmatier; Xiu Liu; Anthony R Caggiula; Eric C Donny; Alan F Sved
Journal:  Neuropsychopharmacology       Date:  2006-11-08       Impact factor: 7.853

7.  Similar precipitated withdrawal effects on intracranial self-stimulation during chronic infusion of an e-cigarette liquid or nicotine alone.

Authors:  A C Harris; P Muelken; J R Smethells; M Krueger; M G LeSage
Journal:  Pharmacol Biochem Behav       Date:  2017-09-01       Impact factor: 3.533

Review 8.  Constitutional mechanisms of vulnerability and resilience to nicotine dependence.

Authors:  N Hiroi; D Scott
Journal:  Mol Psychiatry       Date:  2009-02-24       Impact factor: 15.992

Review 9.  Abuse liability assessment of tobacco products including potential reduced exposure products.

Authors:  Lawrence P Carter; Maxine L Stitzer; Jack E Henningfield; Rich J O'Connor; K Michael Cummings; Dorothy K Hatsukami
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

10.  Nondaily Smokers' Changes in Cigarette Consumption With Very Low-Nicotine-Content Cigarettes: A Randomized Double-blind Clinical Trial.

Authors:  Saul Shiffman; Brenda F Kurland; Sarah M Scholl; Jason M Mao
Journal:  JAMA Psychiatry       Date:  2018-10-01       Impact factor: 21.596

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.